 |
 |

Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina
 |
 |
| Since this article does not have an abstract, we have provided the first 79 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Chaitman and colleagues1 did not present detailed safety data. In particular, we would be interested in knowing the effect ranolazine has on kidneys, liver, blood cells, or metabolism, as well as on quality of life and hospital admission rates. Furthermore, the authors reported that 30% to 41% of subjects stopped taking ranolazine, but they did not present their subsequent clinical events. The fate of these individuals is critical in assessing the safety of this drug.
Christoph Pechlaner, MD
christoph.pechlaner@uibk.ac.at Innsbruck University Hospital Innsbruck, Austria
Christian Wiedermann, MD
General Hospital of Bolzano Bolzano, Italy
1. Chaitman BR, Pepine CJ, Parker JO, et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA. 2004;291:309-316.
FREE FULL TEXT
Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.
JAMA. 2004;291:1959.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina
and
JAMA. ;291():1959-1959.
FULL TEXT
Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina--Reply
JAMA. ;291():1959-1960.
FULL TEXT
Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic Angina: A Randomized Controlled Trial
, , , , , , , , and
JAMA. ;291():309-316.
FULL TEXT
|